Hallazgo, Retchel .

HRN: 22-21-71  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2022
CEFUROXIME 500MG (TAB)
12/26/2022
01/01/2023
ORAL
500mg
BID
Thickly MSAF
Waiting Final Action 
12/26/2022
METRONIDAZOLE 500MG (TAB)
12/26/2022
01/01/2023
ORAL
500mg
Tid
Thickly MSAF
Waiting Final Action 
12/26/2022
CO-AMOXICLAV 625MG (TAB)
12/26/2022
01/02/2023
ORAL
625mg
Q12
T/C Endometritis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: